bullish

Activolabs

Aktivolabs scores US$10M Series A to help populations manage risk of chronic diseases

645 Views21 Dec 2022 12:20
Syndicated
Aktivolabs harnesses real-time digital health data elements in a low-touch, cost-effective manner with measurable actuarial and actionable value to life and health insurers
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 2-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
e27
Research from e27
e27
Multi-AssetPrivate Capital Markets
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x